LinkedIn Profile

Access Magnolia Medical Technologies historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
private:magnoliamedicaltechnologies 3204787 Dec 3rd, 2020 12:00AM Magnolia Medical Technologies 1.1K 61.00 Open Medical Device Dec 3rd, 2020 11:29AM Dec 3rd, 2020 11:29AM Magnolia Medical Technologies develops, manufactures and markets innovative blood collection devices that significantly improve the accuracy of critical laboratory tests. As a company we are focused on establishing a new standard for sepsis testing accuracy to drive antibiotic stewardship, improve patient safety, impact key quality outcomes and significantly reduce healthcare costs. Magnolia’s flagship commercial product, Steripath® (Initial Specimen Diversion Device®), is the only FDA-cleared device indicated to reduce blood culture contamination which causes false positive sepsis test results. Steripath has been evaluated exhaustively in 14 clinical studies, including 5 peer-reviewed publications, and has demonstrated sustained reductions in contamination of up to 92%. Steripath has been clinically adopted by leading academic institutions, government military & VA medical centers and large & small community hospitals across the country -- successfully reducing the risks of false-positive sepsis results for over 1 million patients. Magnolia has developed a wide range of products to significantly improve diagnostic specimen quality aimed at directly and dramatically increasing diagnostic accuracy for critical laboratory tests. The company’s intellectual property portfolio includes more than 70 issued patents with more than 50 additional patent applications pending. For more information, visit www.magnolia-medical.com Open Healthcare, Hospital, Emergency Departments, Antimicrobial Stewardship, Nursing, Medical Reimbursement, Sepsis Prevention, Accurate Blood Testing, Medical Devices, Hospital Reimbursement, Hospital, Medical Technology, Healthcare Technology, Blood Culture Collection, Infectious Disease Prevention Open 200 W. Mercer Street Seattle WA US 98119 Magnolia Medical Technologies Pharmaceuticals & Biotechnology
private:magnoliamedicaltechnologies 3204787 Dec 2nd, 2020 12:00AM Magnolia Medical Technologies 1.1K 61.00 Open Medical Device Dec 2nd, 2020 01:50PM Dec 2nd, 2020 01:50PM Magnolia Medical Technologies develops, manufactures and markets innovative blood collection devices that significantly improve the accuracy of critical laboratory tests. As a company we are focused on establishing a new standard for sepsis testing accuracy to drive antibiotic stewardship, improve patient safety, impact key quality outcomes and significantly reduce healthcare costs. Magnolia’s flagship commercial product, Steripath® (Initial Specimen Diversion Device®), is the only FDA-cleared device indicated to reduce blood culture contamination which causes false positive sepsis test results. Steripath has been evaluated exhaustively in 14 clinical studies, including 5 peer-reviewed publications, and has demonstrated sustained reductions in contamination of up to 92%. Steripath has been clinically adopted by leading academic institutions, government military & VA medical centers and large & small community hospitals across the country -- successfully reducing the risks of false-positive sepsis results for over 1 million patients. Magnolia has developed a wide range of products to significantly improve diagnostic specimen quality aimed at directly and dramatically increasing diagnostic accuracy for critical laboratory tests. The company’s intellectual property portfolio includes more than 70 issued patents with more than 50 additional patent applications pending. For more information, visit www.magnolia-medical.com Open Healthcare, Hospital, Emergency Departments, Antimicrobial Stewardship, Nursing, Medical Reimbursement, Sepsis Prevention, Accurate Blood Testing, Medical Devices, Hospital Reimbursement, Hospital, Medical Technology, Healthcare Technology, Blood Culture Collection, Infectious Disease Prevention Open 200 W. Mercer Street Seattle WA US 98119 Magnolia Medical Technologies Pharmaceuticals & Biotechnology
private:magnoliamedicaltechnologies 3204787 Dec 1st, 2020 12:00AM Magnolia Medical Technologies 1.1K 61.00 Open Medical Device Dec 1st, 2020 01:23PM Dec 1st, 2020 01:23PM Magnolia Medical Technologies develops, manufactures and markets innovative blood collection devices that significantly improve the accuracy of critical laboratory tests. As a company we are focused on establishing a new standard for sepsis testing accuracy to drive antibiotic stewardship, improve patient safety, impact key quality outcomes and significantly reduce healthcare costs. Magnolia’s flagship commercial product, Steripath® (Initial Specimen Diversion Device®), is the only FDA-cleared device indicated to reduce blood culture contamination which causes false positive sepsis test results. Steripath has been evaluated exhaustively in 14 clinical studies, including 5 peer-reviewed publications, and has demonstrated sustained reductions in contamination of up to 92%. Steripath has been clinically adopted by leading academic institutions, government military & VA medical centers and large & small community hospitals across the country -- successfully reducing the risks of false-positive sepsis results for over 1 million patients. Magnolia has developed a wide range of products to significantly improve diagnostic specimen quality aimed at directly and dramatically increasing diagnostic accuracy for critical laboratory tests. The company’s intellectual property portfolio includes more than 70 issued patents with more than 50 additional patent applications pending. For more information, visit www.magnolia-medical.com Open Healthcare, Hospital, Emergency Departments, Antimicrobial Stewardship, Nursing, Medical Reimbursement, Sepsis Prevention, Accurate Blood Testing, Medical Devices, Hospital Reimbursement, Hospital, Medical Technology, Healthcare Technology, Blood Culture Collection, Infectious Disease Prevention Open 200 W. Mercer Street Seattle WA US 98119 Magnolia Medical Technologies Pharmaceuticals & Biotechnology
private:magnoliamedicaltechnologies 3204787 Nov 30th, 2020 12:00AM Magnolia Medical Technologies 1.1K 61.00 Open Medical Device Nov 29th, 2020 07:28PM Nov 30th, 2020 02:15PM Magnolia Medical Technologies develops, manufactures and markets innovative blood collection devices that significantly improve the accuracy of critical laboratory tests. As a company we are focused on establishing a new standard for sepsis testing accuracy to drive antibiotic stewardship, improve patient safety, impact key quality outcomes and significantly reduce healthcare costs. Magnolia’s flagship commercial product, Steripath® (Initial Specimen Diversion Device®), is the only FDA-cleared device indicated to reduce blood culture contamination which causes false positive sepsis test results. Steripath has been evaluated exhaustively in 14 clinical studies, including 5 peer-reviewed publications, and has demonstrated sustained reductions in contamination of up to 92%. Steripath has been clinically adopted by leading academic institutions, government military & VA medical centers and large & small community hospitals across the country -- successfully reducing the risks of false-positive sepsis results for over 1 million patients. Magnolia has developed a wide range of products to significantly improve diagnostic specimen quality aimed at directly and dramatically increasing diagnostic accuracy for critical laboratory tests. The company’s intellectual property portfolio includes more than 70 issued patents with more than 50 additional patent applications pending. For more information, visit www.magnolia-medical.com Open Healthcare, Hospital, Emergency Departments, Antimicrobial Stewardship, Nursing, Medical Reimbursement, Sepsis Prevention, Accurate Blood Testing, Medical Devices, Hospital Reimbursement, Hospital, Medical Technology, Healthcare Technology, Blood Culture Collection, Infectious Disease Prevention Open 200 W. Mercer Street Seattle WA US 98119 Magnolia Medical Technologies Pharmaceuticals & Biotechnology
private:magnoliamedicaltechnologies 3204787 Nov 28th, 2020 12:00AM Magnolia Medical Technologies 1.1K 61.00 Open Medical Device Nov 28th, 2020 03:03PM Nov 28th, 2020 03:03PM Magnolia Medical Technologies develops, manufactures and markets innovative blood collection devices that significantly improve the accuracy of critical laboratory tests. As a company we are focused on establishing a new standard for sepsis testing accuracy to drive antibiotic stewardship, improve patient safety, impact key quality outcomes and significantly reduce healthcare costs. Magnolia’s flagship commercial product, Steripath® (Initial Specimen Diversion Device®), is the only FDA-cleared device indicated to reduce blood culture contamination which causes false positive sepsis test results. Steripath has been evaluated exhaustively in 14 clinical studies, including 5 peer-reviewed publications, and has demonstrated sustained reductions in contamination of up to 92%. Steripath has been clinically adopted by leading academic institutions, government military & VA medical centers and large & small community hospitals across the country -- successfully reducing the risks of false-positive sepsis results for over 1 million patients. Magnolia has developed a wide range of products to significantly improve diagnostic specimen quality aimed at directly and dramatically increasing diagnostic accuracy for critical laboratory tests. The company’s intellectual property portfolio includes more than 70 issued patents with more than 50 additional patent applications pending. For more information, visit www.magnolia-medical.com Open Healthcare, Hospital, Emergency Departments, Antimicrobial Stewardship, Nursing, Medical Reimbursement, Sepsis Prevention, Accurate Blood Testing, Medical Devices, Hospital Reimbursement, Hospital, Medical Technology, Healthcare Technology, Blood Culture Collection, Infectious Disease Prevention Open 200 W. Mercer Street Seattle WA US 98119 Magnolia Medical Technologies Pharmaceuticals & Biotechnology
private:magnoliamedicaltechnologies 3204787 Nov 27th, 2020 12:00AM Magnolia Medical Technologies 1.1K 61.00 Open Medical Device Nov 27th, 2020 11:28AM Nov 27th, 2020 11:28AM Magnolia Medical Technologies develops, manufactures and markets innovative blood collection devices that significantly improve the accuracy of critical laboratory tests. As a company we are focused on establishing a new standard for sepsis testing accuracy to drive antibiotic stewardship, improve patient safety, impact key quality outcomes and significantly reduce healthcare costs. Magnolia’s flagship commercial product, Steripath® (Initial Specimen Diversion Device®), is the only FDA-cleared device indicated to reduce blood culture contamination which causes false positive sepsis test results. Steripath has been evaluated exhaustively in 14 clinical studies, including 5 peer-reviewed publications, and has demonstrated sustained reductions in contamination of up to 92%. Steripath has been clinically adopted by leading academic institutions, government military & VA medical centers and large & small community hospitals across the country -- successfully reducing the risks of false-positive sepsis results for over 1 million patients. Magnolia has developed a wide range of products to significantly improve diagnostic specimen quality aimed at directly and dramatically increasing diagnostic accuracy for critical laboratory tests. The company’s intellectual property portfolio includes more than 70 issued patents with more than 50 additional patent applications pending. For more information, visit www.magnolia-medical.com Open Healthcare, Hospital, Emergency Departments, Antimicrobial Stewardship, Nursing, Medical Reimbursement, Sepsis Prevention, Accurate Blood Testing, Medical Devices, Hospital Reimbursement, Hospital, Medical Technology, Healthcare Technology, Blood Culture Collection, Infectious Disease Prevention Open 200 W. Mercer Street Seattle WA US 98119 Magnolia Medical Technologies Pharmaceuticals & Biotechnology
private:magnoliamedicaltechnologies 3204787 Nov 26th, 2020 12:00AM Magnolia Medical Technologies 1.1K 61.00 Open Medical Device Nov 26th, 2020 12:27PM Nov 26th, 2020 12:27PM Magnolia Medical Technologies develops, manufactures and markets innovative blood collection devices that significantly improve the accuracy of critical laboratory tests. As a company we are focused on establishing a new standard for sepsis testing accuracy to drive antibiotic stewardship, improve patient safety, impact key quality outcomes and significantly reduce healthcare costs. Magnolia’s flagship commercial product, Steripath® (Initial Specimen Diversion Device®), is the only FDA-cleared device indicated to reduce blood culture contamination which causes false positive sepsis test results. Steripath has been evaluated exhaustively in 14 clinical studies, including 5 peer-reviewed publications, and has demonstrated sustained reductions in contamination of up to 92%. Steripath has been clinically adopted by leading academic institutions, government military & VA medical centers and large & small community hospitals across the country -- successfully reducing the risks of false-positive sepsis results for over 1 million patients. Magnolia has developed a wide range of products to significantly improve diagnostic specimen quality aimed at directly and dramatically increasing diagnostic accuracy for critical laboratory tests. The company’s intellectual property portfolio includes more than 70 issued patents with more than 50 additional patent applications pending. For more information, visit www.magnolia-medical.com Open Healthcare, Hospital, Emergency Departments, Antimicrobial Stewardship, Nursing, Medical Reimbursement, Sepsis Prevention, Accurate Blood Testing, Medical Devices, Hospital Reimbursement, Hospital, Medical Technology, Healthcare Technology, Blood Culture Collection, Infectious Disease Prevention Open 200 W. Mercer Street Seattle WA US 98119 Magnolia Medical Technologies Pharmaceuticals & Biotechnology
private:magnoliamedicaltechnologies 3204787 Nov 25th, 2020 12:00AM Magnolia Medical Technologies 1.1K 61.00 Open Medical Device Nov 25th, 2020 05:51PM Nov 25th, 2020 05:51PM Magnolia Medical Technologies develops, manufactures and markets innovative blood collection devices that significantly improve the accuracy of critical laboratory tests. As a company we are focused on establishing a new standard for sepsis testing accuracy to drive antibiotic stewardship, improve patient safety, impact key quality outcomes and significantly reduce healthcare costs. Magnolia’s flagship commercial product, Steripath® (Initial Specimen Diversion Device®), is the only FDA-cleared device indicated to reduce blood culture contamination which causes false positive sepsis test results. Steripath has been evaluated exhaustively in 14 clinical studies, including 5 peer-reviewed publications, and has demonstrated sustained reductions in contamination of up to 92%. Steripath has been clinically adopted by leading academic institutions, government military & VA medical centers and large & small community hospitals across the country -- successfully reducing the risks of false-positive sepsis results for over 1 million patients. Magnolia has developed a wide range of products to significantly improve diagnostic specimen quality aimed at directly and dramatically increasing diagnostic accuracy for critical laboratory tests. The company’s intellectual property portfolio includes more than 70 issued patents with more than 50 additional patent applications pending. For more information, visit www.magnolia-medical.com Open Healthcare, Hospital, Emergency Departments, Antimicrobial Stewardship, Nursing, Medical Reimbursement, Sepsis Prevention, Accurate Blood Testing, Medical Devices, Hospital Reimbursement, Hospital, Medical Technology, Healthcare Technology, Blood Culture Collection, Infectious Disease Prevention Open 200 W. Mercer Street Seattle WA US 98119 Magnolia Medical Technologies Pharmaceuticals & Biotechnology
private:magnoliamedicaltechnologies 3204787 Nov 24th, 2020 12:00AM Magnolia Medical Technologies 1.1K 61.00 Open Medical Device Nov 24th, 2020 01:07PM Nov 24th, 2020 01:07PM Magnolia Medical Technologies develops, manufactures and markets innovative blood collection devices that significantly improve the accuracy of critical laboratory tests. As a company we are focused on establishing a new standard for sepsis testing accuracy to drive antibiotic stewardship, improve patient safety, impact key quality outcomes and significantly reduce healthcare costs. Magnolia’s flagship commercial product, Steripath® (Initial Specimen Diversion Device®), is the only FDA-cleared device indicated to reduce blood culture contamination which causes false positive sepsis test results. Steripath has been evaluated exhaustively in 14 clinical studies, including 5 peer-reviewed publications, and has demonstrated sustained reductions in contamination of up to 92%. Steripath has been clinically adopted by leading academic institutions, government military & VA medical centers and large & small community hospitals across the country -- successfully reducing the risks of false-positive sepsis results for over 1 million patients. Magnolia has developed a wide range of products to significantly improve diagnostic specimen quality aimed at directly and dramatically increasing diagnostic accuracy for critical laboratory tests. The company’s intellectual property portfolio includes more than 70 issued patents with more than 50 additional patent applications pending. For more information, visit www.magnolia-medical.com Open Healthcare, Hospital, Emergency Departments, Antimicrobial Stewardship, Nursing, Medical Reimbursement, Sepsis Prevention, Accurate Blood Testing, Medical Devices, Hospital Reimbursement, Hospital, Medical Technology, Healthcare Technology, Blood Culture Collection, Infectious Disease Prevention Open 200 W. Mercer Street Seattle WA US 98119 Magnolia Medical Technologies Pharmaceuticals & Biotechnology
private:magnoliamedicaltechnologies 3204787 Nov 23rd, 2020 12:00AM Magnolia Medical Technologies 1.1K 61.00 Open Medical Device Nov 23rd, 2020 03:09PM Nov 23rd, 2020 03:09PM Magnolia Medical Technologies develops, manufactures and markets innovative blood collection devices that significantly improve the accuracy of critical laboratory tests. As a company we are focused on establishing a new standard for sepsis testing accuracy to drive antibiotic stewardship, improve patient safety, impact key quality outcomes and significantly reduce healthcare costs. Magnolia’s flagship commercial product, Steripath® (Initial Specimen Diversion Device®), is the only FDA-cleared device indicated to reduce blood culture contamination which causes false positive sepsis test results. Steripath has been evaluated exhaustively in 14 clinical studies, including 5 peer-reviewed publications, and has demonstrated sustained reductions in contamination of up to 92%. Steripath has been clinically adopted by leading academic institutions, government military & VA medical centers and large & small community hospitals across the country -- successfully reducing the risks of false-positive sepsis results for over 1 million patients. Magnolia has developed a wide range of products to significantly improve diagnostic specimen quality aimed at directly and dramatically increasing diagnostic accuracy for critical laboratory tests. The company’s intellectual property portfolio includes more than 70 issued patents with more than 50 additional patent applications pending. For more information, visit www.magnolia-medical.com Open Healthcare, Hospital, Emergency Departments, Antimicrobial Stewardship, Nursing, Medical Reimbursement, Sepsis Prevention, Accurate Blood Testing, Medical Devices, Hospital Reimbursement, Hospital, Medical Technology, Healthcare Technology, Blood Culture Collection, Infectious Disease Prevention Open 200 W. Mercer Street Seattle WA US 98119 Magnolia Medical Technologies Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.